Hot Selling for Cryptococcal Capsular Polysaccharide Detection Kit (CLIA) - Carbapenem-resistant IMP Detection K-Set (Lateral Flow Assay) – Genobio


Product Detail

Product Tags

Related Video

Feedback (2)

We take pleasure in an extremely fantastic standing among the our prospects for our great product top quality, competitive cost and the finest support for candida real-time PCR, bacteria test kit, Cryptococcal Capsular Polysaccharide Detection K-Set (Lateral Flow Assay), Sincere cooperation with you, altogether will create happy tomorrow!
Hot Selling for Cryptococcal Capsular Polysaccharide Detection Kit (CLIA) - Carbapenem-resistant IMP Detection K-Set (Lateral Flow Assay) – Genobio Detail:

Product Introduction

The Carbapenem-resistant IMP Detection K-Set (Lateral Flow Assay) is an immunochromatographic test system intended for the qualitative detection of IMP-type carbapenemase in bacterial colonies. The assay is a prescription-use laboratory assay which can aid in the diagnosis of IMP-type carbapenem resistant strains.

Carbapenem-resistant NDM Detection K-Set (Lateral Flow Assay) 1

Characteristics

Name

Carbapenem-resistant IMP Detection K-Set (Lateral Flow Assay)

Method

Lateral Flow Assay

Sample type

Bacterial colonies

Specification

25 tests/kit

Detection time

10-15 min

Detection objects

Carbapenem-resistant Enterobacteriaceae (CRE)

Detection type

IMP

Stability

The K-Set is stable for 2 years at 2°C-30°C

Carbapenem-resistant IMP

Advantage

  • Rapid
    Obtain result within 15 min, 3 days earlier than traditional detection methods
  • Simple
    Easy to use, ordinary laboratory staff can operate without training
  • Accurate
    High sensitivity and specificity
    Low detection limit: 0.20 ng/mL
    Able to detect most of the common subtypes of IMP
  • Intuitive result
    There is no need for calculation, visual reading result
  • Economic
    Product can be transported and stored at room temperature, reducing costs

The importance of CRE test

Collectively, Enterobacterales are the most common group of pathogens causing healthcare-associated infections. Some Enterobacterales can produce an enzyme called a carbapenemase that makes antibiotics like carbapenems, penicillins, and cephalosporins ineffective. For this reason, CRE have been called “nightmare bacteria” because there are few alternative antibiotics, if any, left to treat the infections caused by these germs.

Bacteria from the Enterobacterales family, including Klebsiella species and Escherichia coli, can produce a carbapenemase. Carbapenemases are often produced from genes located on transferable elements that can spread resistance easily from germ to germ and person to person. Also because of the abuse usage of antibiotics and limited methods taken to prevent spreading, the dramatically increasing CRE problem is becoming a life threat worldwide.

Usually, spread of CRE can be controlled by:

  • Monitoring CRE infections
  • Isolate patients with CRE
  • Removing invasive medical devices inside the body
  • Be careful when prescribing antibiotics (especially carbapenems)
  • Using clean sterile techniques to minimize the spread of infection
  • Strictly follow the lab cleaning routine

……
CRE detection is of great value in spread control. By testing early, health providers can give a more reasonable therapy to patients susceptible to CRE, also achieve the hospitalization management.

IMP-type carbapenemase

Carbapenemase refers to a type of β-lactamase that can at least significantly hydrolyze imipenem or meropenem, including A, B, D three types of enzymes classified by Ambler molecular structure. Among them, Class B are metallo-β-lactamases (MBLs), including carbapenemases such as IMP, VIM and NDM,. IMP-type carbapenemase, also known as imipenemase metallo-beta-lactamase producing CRE, is a very common kind of acquired MBLs and is from subclass 3A. It can hydrolyze almost all β-lactam antibiotics.

Operation

  • Add 5 drops of sample treatment solution
  • Dip bacterial colonies with a disposable inoculation loop
  • Insert the loop into the tube
  • Add 50 μL to the S well, wait for 10-15 minutes
  • Read the result

Carbapenem-resistant KPC Detection K-Set (Lateral Flow Assay) 2

Order Information

Model

Description

Product code

CPI-01

25 tests/kit

CPI-01


Product detail pictures:

Hot Selling for Cryptococcal Capsular Polysaccharide Detection Kit (CLIA) - Carbapenem-resistant IMP Detection K-Set (Lateral Flow Assay) – Genobio detail pictures


Related Product Guide:

We have the most advanced production equipment, experienced and qualified engineers and workers, recognized quality control systems and a friendly professional sales team pre/after-sales support for Hot Selling for Cryptococcal Capsular Polysaccharide Detection Kit (CLIA) - Carbapenem-resistant IMP Detection K-Set (Lateral Flow Assay) – Genobio , The product will supply to all over the world, such as: Milan, South Africa, Mauritius, They're durable modeling and promoting effectively all over the world. Under no circumstances disappearing major functions in a quick time, it's a should for you of excellent good quality. Guided by the principle of "Prudence, Efficiency, Union and Innovation. the company make a terrific efforts to expand its international trade, raise its company profit and raise its export scale. We're confident that we are going to possess a vibrant prospect and to be distributed all over the world within the years to come.
  • The company leader recept us warmly, through a meticulous and thorough discussion, we signed a purchase order. Hope to cooperate smoothly
    5 Stars By Debby from Libya - 2017.11.01 17:04
    As an international trading company, we have numerous partners, but about your company, I just want to say, you are really good, wide range, good quality, reasonable prices, warm and thoughtful service, advanced technology and equipment and workers have professional training, feedback and product update is timely, in short, this is a very pleasant cooperation, and we look forward to the next cooperation!
    5 Stars By Julie from Moldova - 2017.09.28 18:29
    Write your message here and send it to us